0001179110-21-009149.txt : 20211004 0001179110-21-009149.hdr.sgml : 20211004 20211004162001 ACCESSION NUMBER: 0001179110-21-009149 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211004 DATE AS OF CHANGE: 20211004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MULLEN JAMES C CENTRAL INDEX KEY: 0001226288 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 211302999 MAIL ADDRESS: STREET 1: 940 WINTER STREET STREET 2: PERKINELMER, INC LEGAL DEPARTMENT CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 edgar.xml FORM 4 - X0306 4 2021-09-30 0 0001650664 Editas Medicine, Inc. EDIT 0001226288 MULLEN JAMES C C/O EDITAS MEDICINE, INC., 11 HURLEY ST. CAMBRIDGE MA 02141 1 1 0 0 CEO Common Stock 2021-09-30 4 A 0 36478 0 A 71478 D Reflects the vesting, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on March 2, 2021. /s/ James C. Mullen 2021-10-04